All Stories

  1. The histamine H4 receptor antagonist 1-[(5-chloro-2,3-dihydro-1-benzofuran-2-yl)methyl]-4-methyl-piperazine(LINS01007) prevents the development of DSS-induced colitis in mice
  2. Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer
  3. Investigation of Structure–Activity Relationships for Benzoyl and Cinnamoyl Piperazine/Piperidine Amides as Tyrosinase Inhibitors
  4. Piperazine amides with desirable solubility, physicochemical and drug-like properties: Synthesis and evaluation of the anti-Trypanosoma cruzi activity
  5. Toward anthelmintic drug candidates for toxocariasis: Challenges and recent developments
  6. Lethal action of Licarin A derivatives in Leishmania (L.) infantum: Imbalance of calcium and bioenergetic metabolism
  7. Synthetic Analogues of Gibbilimbol B Induce Bioenergetic Damage and Calcium Imbalance in Trypanosoma cruzi
  8. Esterification of p-Coumaric Acid Improves the Control over Melanoma Cell Growth
  9. Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H3 and dopamine D3 receptors
  10. Neurotoxicity Assessment of 1-[(2,3-Dihydro-1-Benzofuran-2-yl)Methyl]Piperazine (LINS01 Series) Derivatives and their Protective Effect on Cocaine-Induced Neurotoxicity Model in SH-SY5Y Cell Culture
  11. Orofacial myofunctional assessment and quality of life of individuals with Parkinson's disease
  12. Evaluation of the histamine H3 receptor antagonists from LINS01 series as cholinesterases inhibitors: Enzymatic and modeling studies
  13. Histamine research advancements in the second year of the COVID-19 pandemic: report of the European Histamine Research Society (EHRS)
  14. Optimization of physicochemical properties is a strategy to improve drug-likeness associated with activity: Novel active and selective compounds against Trypanosoma cruzi
  15. Bioisosteric modification on benzylidene‐carbonyl compounds improved the drug‐likeness and maintained the antifungal activity against Sporothrix brasiliensis
  16. Histamine H3 receptor and cholinesterases as synergistic targets for cognitive decline: Strategies to the rational design of multitarget ligands
  17. Metabolite profile of Nectandra oppositifolia Nees & Mart. and assessment of antitrypanosomal activity of bioactive compounds through efficiency analyses
  18. Novel potent (dihydro)benzofuranyl piperazines as human histamine receptor ligands – Functional characterization and modeling studies on H3 and H4 receptors
  19. Assessment of the Physicochemical Properties and Stability for Pharmacokinetic Prediction of Pyrazinoic Acid Derivatives
  20. Relationship between polypharmacy, xerostomia, gustatory sensitivity, and swallowing complaints in the elderly: A multidisciplinary approach
  21. The Novel H4R Antagonist 1-[(5-Chloro-2,3-Dihydro-1-Benzofuran-2-Yl)Methyl]-4-Methyl-Piperazine (LINS01007) Attenuates Several Symptoms in Murine Allergic Asthma
  22. Total Parenteral Nutrition and Neuroleptic Malignant-Like Syndrome in Parkinson Disease
  23. Coumaric acid analogues inhibit growth and melanin biosynthesis in Cryptococcus neoformans and potentialize amphotericin B antifungal activity
  24. Coumaric acid derivatives as tyrosinase inhibitors: Efficacy studies through in silico, in vitro and ex vivo approaches
  25. Benzylidene-carbonyl compounds are active against itraconazole-susceptible and itraconazole-resistant Sporothrix brasiliensis
  26. Natural Products: Key Prototypes to Drug Discovery Against Neglected Diseases Caused by Trypanosomatids
  27. Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A
  28. Novel potent vasodilating agents: Evaluation of the activity and potency of LINS01005 and derivatives in rat aorta
  29. Differential contribution of H3R antagonism by LINS01 compounds on memory, anxiety-like behaviour and spontaneous locomotor activity in healthy rats
  30. Profiling of LINS01 compounds at human dopamine D2 and D3 receptors
  31. Evaluation of the antitrypanosoma activity and SAR study of novel LINS03 derivatives
  32. Targeting the Histamine H4 Receptor: Future Drugs for Inflammatory Diseases
  33. Pyrazinoates as antiparasitic agents against Trypanosoma cruzi
  34. Antiparasitic activity of new gibbilimbol analogues and SAR analysis through efficiency and statistical methods
  35. Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H1 , H2 and H3 receptors
  36. QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
  37. The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist’s Education
  38. Anti-Sporothrix brasiliensis activity of different pyrazinoic acid prodrugs: a repurposing evaluation
  39. Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H3 and H4 Receptors with Anti-inflammatory Potential
  40. Evaluation of β-Aminocarboxylic Acid Derivatives in Hippocampal Excitatory Synaptic Transmission
  41. New alkenyl derivative from Piper malacophyllum and analogues: Antiparasitic activity against Trypanosoma cruzi and Leishmania infantum
  42. 1-[(2,3-Dihydro-1-benzofuran-2-yl) methyl]piperazines as novel anti-inflammatory compounds: Synthesis and evaluation on H3R/H4R
  43. Factorial study to assess an ultrasonic methodology for the allylation of 4-chloroaniline
  44. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis
  45. Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes Against Tuberculosis
  46. Gibbilimbol analogues as antiparasitic agents—Synthesis and biological activity against Trypanosoma cruzi and Leishmania (L.) infantum
  47. Factorial design study to access the “green” iodocyclization reaction of 2-allylphenols
  48. Histamine H4 Receptor Ligands: Future Applications and State of Art
  49. Synthesis and evaluation of a pyrazinoic acid prodrug in Mycobacterium tuberculosis
  50. Estudo das relações entre estrutura e atividade de parabenos: uma aula prática
  51. Cytotoxicity evaluation ofCurcuma zedoaria(Christm.) Roscoe fluid extract used in oral hygiene products
  52. Optimization of the ultrasound-assisted synthesis of allyl 1-naphthyl ether using response surface methodology
  53. Molecular modeling and QSAR studies of a set of indole and benzimidazole derivatives as H4 receptor antagonists
  54. QSAR Modeling of a Set of Pyrazinoate Esters as Antituberculosis Prodrugs
  55. Simple and Efficient Access to 3-Ethoxycarbonylpyrroles, Benzofurans, and Naphthofurans
  56. Evaluation of the influence of base and alkyl bromide on synthesis of pyrazinoic acid esters through fatorial design
  57. Planejamento e sintese de compostos potencialmente ligantes dos receptores 5-HT2C e H4
  58. Síntese e atividade antimicobacteriana de ésteres do ácido pirazinóico e quinolonas